
Test Template Ronny Allan
Discover more from Ronny Allan – Living with Neuroendocrine Cancer Subscribe to get the latest posts sent to your email. Type your email… Subscribe

Buy me a cup of tea or two? Change the number below to increment. i.e insert 2 = £8, 3 = £12, etc
Overheads to run this site, e.g. software packages, domain registration fees, software tools, misc items. Donate £4 or more so I have the fuel to keep on providing great content!
£4.00
There’s a lot of inaccurate and out-of-date information out there. Some are just a lack of understanding, and some are caused by out-of-date websites. Often the problem is a result of patient forum myth spreading exacerbated by poor moderation in the groups concerned. Some can only be described as propaganda. Some of it even comes from uninformed doctors and bizarrely and disappointingly from NET advocate organisations.
All the graphics below contain links to relevant blog posts.
Simply untrue. They are a heterogeneous group of tumours. Read more here
Not true. By any definition of the word terminal in a medical diagnostic context, most NET patients have a good prognostic outlook, even those with metastatic and incurable variants of the disease. Read more here.
Not true. By any scientific definition, the word ‘tumour’ means ‘an abnormal mass of tissue that results when cells divide more than they should or do not die when they should. However, since the World Health Organisation (WHO) 2010 classification for digestive systems, the situation has been based on the concept that all NETs have malignant potential, and therefore abandoned the division into benign and malignant NETs and tumours of uncertain malignant potential. This has been reinforced in the 2017 Endocrine update to include clarification for endocrine organ types of NET including Pheochromocytoma and subsequently (and more forcefully) in the 2019 Digestive Systems update. Finally it was rubberstamped in the 2022 WHO Classification when NETs wire finally corralled into a single classification publication. Read more here. The word ‘Carcinoid’ is inextricably linked with this issue – read here why we need to stop using the term to help fight the benign myth. Finally, a 2024 quote confirming something which confused patients and others. Read more here.
Not true. Aside from the ridiculous grammar i.e. “Neuroendocrine Tumour Cancer, this is not the way to describe our cancer and it’s an utter disgrace that this continues to be acceptable by some. The correct terms can be found by reading here
Not true. Carcinoid is a very old term and was phased out years ago. Carcinoid is not mentioned in the latest WHO Classification schemes for Neuroendocrine Neoplasms (a term covering Neuroendocrine Tumours and Neuroendocrine Carcinoma). Unfortunately, the problem is exacerbated by organisations and individuals who still use the word. Also, those who use the following terms:
These are all contextually incorrect and misleading terms (not to mention the bad grammar). ENETS, NANETS and NCCN publications are gradually phasing the word out except in relation to Carcinoid Syndrome (and even then, there could be easy solutions for this). Doctors (including some NET specialists) and patient organisations need to catch up. Read more here and here.
Not true. Firstly, many NETs are non-functional; and secondly, carcinoid syndrome is only one of a number of “NET Syndromes” and is only associated with serotonin-secreting NETs. However, the issue is further confused by those who use the word ‘Carcinoid‘ to incorrectly refer to all NETs and use Carcinoid Syndrome to refer to all NET Syndromes.
When you read the content of the average social media patient group, it’s almost as if everyone has a syndrome, and often there is only one syndrome mentioned. The issue is exacerbated by health sites (including NET sites) that only talk about carcinoid and carcinoid syndrome as if it applies to all NETs. Moreover, statistics collected over decades are ignored and this issue is exacerbated by flawed statistics emanating from certain advocate organisations that take most of their data from late-stage syndromic patients and then apply it to everyone. But in reality, only 10% of cases involve carcinoid syndrome (where that syndrome is appropriate).
Read more here.
Not true. As a collective grouping of cancers, this is no longer accurate. Read more here. Also, check out my post about the “Invisible NET Patient Population“.
Not true. Steve Jobs had a Neuroendocrine Tumour of the Pancreas. Ditto for a few other famous names. Read more here.

Not true. Aretha Franklin had a Neuroendocrine Tumour of the Pancreas. Ditto for a few other famous names. Read more here.
Not true. For some cancers or some sub-types of cancers, although it remains an option in certain scenarios, chemotherapy is not particularly effective, e.g. some types of Neuroendocrine Cancer (NETs). In general, well-differentiated NETs do not normally show a high degree of sensitivity to chemotherapy, although some primary locations fare better than others. However, many of the treatments for NETs are somewhat harsh, have long-term consequences, and have no visible effects. NET patients are often said to “look well” but that doesn’t mean they are not struggling behind the scenes or under the surface. Read more here. P.S. Afinitor (Everolimus), Sutent (Sunitinib) are not chemo – Read more here.
Not true. It could be one of the other syndromes or tumor types or a side effect of your treatment. Check out this post.
Not true. Simply, no cancer is good. Some are statistically worse than others in prognostic terms, that’s true…… but living with NETs is very often not a walk in the park. However, no one cancer is better to get than any other – they’re all bad. Read more here.
Not true. Many NET Patients are correctly diagnosed early on in their investigation and in a reasonable time. Also, many are incidentally detected as an investigation leads to a scan or imaging – that is not a misdiagnosis. This myth is perpetuated because of two things: firstly, on forums, the ratio of long-term misdiagnosis is high creating a false perception; and secondly, the method of capturing patient surveys is not extensive enough – again creating a false perception. In fact, the latest and largest database analysis from US indicates earlier diagnosis is improving, with more and more NETs being picked up at an early stage. Read more here.
Not true. Somatostatin Analogues (e.g. Octreotide and Lanreotide) are not chemotherapy, they are hormone-inhibiting drugs. They are more biotherapy. As the drugs latch onto somatostatin receptors, they are more targeted than systemic. For the record, Everolimus (Afinitor) and Sunitinib (Sutent) are not chemotherapy either. Read more here.
Not true. This is a common misunderstanding within the community. He has Pseudomyxoma Peritonei (PMP). Read more about PMP here.
Not true. Many patients live a very long time and lead fairly normal lives with the right treatment and support. It’s difficult but I try not to use ‘I can’t’ too much. Read more here.
Not true. There are many specialists in many countries. Get links to specialists by clicking here
Not true. It is actually replacing the older machines known as Octreotide Scan (or somatostatin receptor scintigraphy (SRS)). Read more by clicking here.
Not true. They are in fact human beings and we should treat them as such. Please don’t call me a zebra, I and many others don’t appreciate it.
Furthermore, it’s becoming abundantly clear that the group of cancers known as Neuroendocrine Neoplasms are no longer rare
Please don’t use the term on my social media sites (including the private Facebook group), the comment or post will be removed. Sorry but I refuse to perpetuate this outdated dogma. Read why here:
The term was originally designed to be used in conjunction with a diagnosis, not a person, an example why certain people and organisations continue to dehumanise you:
Not true. Multiple Endocrine Neoplasia (MEN) are syndromes and inherited disorders not tumours. You can actually have MEN and not have any tumours. However, these disorders can put people at more risk of developing Neuroendocrine or Endocrine Tumours. Read more here
Not true. Palliative care is specialized medical care that focuses on providing patients relief from pain and other symptoms of a serious illness. A multidisciplinary care team aims to improve the quality of life for people who have serious or life-threatening illnesses, no matter the diagnosis or stage of the disease. Read more here
Not true. Serotonin is manufactured in the body. Some dietary sites might be saying this because it simplifies the explanation for readers. Just tell us the facts please! Tell us about tryptophan etc. Read more here
Not true. If caught early enough, some NETs can be treated with curative intent (totally resected with margins) with little or no further follow-up. It says this in publications that are authored by our top specialists. If we can’t believe them, who can we believe? Read more here.
Not true. It’s for any patient who is exhibiting exocrine pancreatic insufficiency. Read more here.
Not true. Since 2017, Grade 3 (high grade) comprises well-differentiated tumours (NETs) and poorly differentiated tumours (Neuroendocrine Carcinomas or NEC). Only poorly differentiated tumours are carcinomas. Read more here.

Not entirely true. Chemo is commonly used in Grade 3 (high grade), particularly poorly differentiated. Also used in some grade 2 scenarios. Read more here.
Not true. Audrey Hepburn had an Appendiceal/Peritoneal malignancy known as Pseudomyxoma Peritonei (PMP). Her son Sean is a patron of the PMP survivor foundation.
Read more here.
Not true. Maria Menounos had a Neuroendocrine Tumour of the Pancreas. Read more here.

Not true. Ronny was diagnosed in 2010. Read more here.
Not true. Read more here.
Not true. This is an oversimplification of a complex disease. Up to 40% of tumors have a genetic link & every tumor possibly can recur. Always check the latest info on https://pheopara.org/
Not true. Neuroendocrine Neoplasms are a heterogenous collection of different sub-types, all needing tailored blood tests. Read more by clicking here or on the picture below.

Not true. Much of what I see in patient groups is total quackery with no scientific basis. Read more by clicking here or on the picture below.


For general cancer myths and the dangers of fake health news, please see my ARTICLE HERE
I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me.
Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional. Some content may be generated by AI which can sometimes be misinterpreted. Please check any references attached.
Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.
Thanks for reading.
Blog Facebook. Like this page please.
Personal Facebook. Like this page please.
Awareness Facebook Like this page please.
Follow me on X (formerly twitter)
Check out my online presentations
Check out my WEGO Health Awards


Discover more from Ronny Allan – Living with Neuroendocrine Cancer Subscribe to get the latest posts sent to your email. Type your email… Subscribe

Bone metastases in Neuroendocrine Tumours (NET) Many of you will know that I am a stage IV small intestine NET and I have one bone

What is Radioligand Therapy? When you browse the internet, you may see the term “Radioligand Therapy (RLT)” and wondered what it was. There’s a simple

D Day I was 54 years and 9 months old at diagnosis on 26th July 2010. For the first few months, I had no idea

USA – Prevalence of Neuroendocrine Neoplasms (NENs) breaches the Orphan Disease threshold for the first time (officially) The latest US SEER figures confirm that staggering

Reframing Neuroendocrine Neoplasms: Beyond “Rare” Neuroendocrine neoplasms (NENs) have outgrown the “rare disease” label. e.g. Across the U.S., UK, and Australia, they now rank among

Sincer 2015, my message has not changed. My message continues to be justified because since then, many important voices in the NEN community have repeated

Here is the monthly summary of September and October 2025 on RonnyAllan.NET – Every share helps someone understand or even work towards a diagnosis,

Scroll down to check out the doctors list just below Scroll down to also see information on “NET Aware” Dietitians. Important note The accuracy of
Subscribe to get the latest posts sent to your email.
Subscribe now to keep reading and get access to the full archive.